drugset / Trial / NCT03598205

Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema

NCT03598205

Completed 72 enrolled Fondazione G.B. Bietti, IRCCS
RandomizedParallel-groupOpen-labelSupportive care

Summary

The aim of the study is to explore the effect of a curcumin formulation in combination to intravitreal dexamethasone therapy in patients with diabetic macular edema on morphological retinal characteristics and retreatment times.

Timeline

Start
2018-02-05
Primary completion
2018-09-28
Completion
2019-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 2 unknown Oral
Background DIABEC plus intravitreal dexamethazone Unknown 0.7 mg